| Weekend Educational Course:
|
| Clinical MR of Cancer |
| Organizers: Naranamangalam
R. Jagannathan, Ph.D., and Daniel B. Vigneron, Ph.D. |
| |
| Skill Level:
Intermediate - Advanced |
| Sunday, 2 May
2010 |
|
|
OVERVIEW |
This one-day course will focus on the
role of clinical MR methods in the evaluation of cancer. It is
designed for physicians (radiologists and oncologists) and for
research scientists who wish to know the current state of the art
and emerging MR techniques for clinical cancer investigations. It
will cover the need for diagnosis, screening and development of
various MR methods like imaging and spectroscopy in the evaluation
of cancer of various organs;
current challenges in clinical diagnosis and management of the
disease, including therapeutic selection, guidance and monitoring;
key biological hallmarks of cancers that are assessable by MRI/MRS
techniques that are ready for clinical translation; evaluation of
the potential and the role of various MR imaging and spectroscopic
techniques for various organ specific cancers and methods of
biomarker qualification processes including the integration of
multi-parametric information using statistical methods and
bioinformatics.
Speakers will be both M.D.s and
Ph.D.s and talks will give the participants a feel for the use of MR
methodology for diagnosis, screening and the relevant biomarkers
that can be used for diagnosis, the assessment of tumor
aggressiveness, therapy response and resistance and be relevant to
the development of novel anti-cancer therapeutics. |
|
|
|
EDUCATIONAL OBJECTIVES |
Upon completion of this course
participants should be able to:
- Describe the role and the
challenges of various MR imaging and spectroscopic methods in
cancer;
- Identify problem areas in cancer
screening, diagnosis and other related issues and how various MR
methods can provide a solution;
- Explain how MRI, MRS and MRSI
biomarkers of cancer are used for diagnosis of cancer, for
therapy planning and for therapeutic outcome assessment;
- Describe the basis and evidence
for MRI biomarkers that are ready for clinical translation; and
- Use bioinformatics to integrate
multi-parametric, multi-spectral imaging information.
|
|
| 08:30 |
Clinical Bottlenecks in
Cancer Journeys |
Clare Tempany
M.D. |
| 09:00 |
Clinical Needs for Therapy
Targeting |
Jelle O.
Barentsz, M.D., Ph.D. |
| 09:30 |
Response Assessments with
Diffusion & Perfusion MRI |
Anwar R. Padhani,
M.R.C.P., F.R.C.R. |
| 10:00 |
Break |
|
| |
10:00 - 10:15 Meet the Teachers
|
|
| |
|
|
| 10:30 |
Diagnosis & Assessment
Response of Cancer: Role for MRS |
N. R.
Jagannathan, Ph.D. |
| 11:00 |
Head and Neck Cancer:
Meeting Challenges with MR |
Amita S. Dave,
Ph.D. |
| 11:30 |
Brain Tumors: Benefits of
Advanced MRI/MRS |
Sarah J.
Nelson, Ph.D. |
| 12:00 |
Break |
|
| |
12:00 - 12:15 - Meet the
Teachers |
|
| |
|
|
| 13:30 |
MRI Biomarkers in Breast
Cancer Clinical Trials |
Nola Hylton,
Ph.D. |
| 14:00 |
The Difficult Liver with
Cancer: Diagnosis with MRI |
Richard C.
Semelka, M.D. |
| 14:30 |
The Problematic Female
Pelvis: Differential Diagnosis with MR |
Lindsay W.
Turnbull M.D. |
| 15:00 |
Break
|
|
| |
15:00 - 15:15 Meet the Teachers
|
|
| |
|
|
| 15:30 |
Musculoskeletal Tumors and
Bony Metastases: Can MR Do Better? |
Laura M. Fayad,
M.D. |
| 16:00 |
Prostate Cancer: Meeting
Clinical Needs with Advanced MR |
John Kurhanewicz,
Ph.D. |
| 16:30 |
Hyperpolarized MR in Cancer: What
It Tells Us about the Future |
Daniel B.
Vigneron, Ph.D. |
| 17:00
|
Automated Brain Cancer
Diagnosis from the Tumor Metabolome |
John R.
Griffiths M.B.B.S., D.Phil. |
| 17:30 |
Adjournment |
|
| |
17:30 - 17:45 - Meet the
Teachers |
|
| |
|
|
|
|
|